University of Medicine and Pharmacy (Romania) Nephrology and Internal Medicine Departament. University of Medicine and Pharmacy (Romania)
|
|
- Ethan White
- 5 years ago
- Views:
Transcription
1 Curriculum vitae PERSONAL INFORMATION Ionut Nistor WORK EXPERIENCE October 2009 Present Lecturer University of Medicine and Pharmacy (Romania) Nephrology and Internal Medicine Departament August 2011 Present Fellow European Renal Best Practice (Belgium) Methods Support Team ERBP, Ghent University. to assist guideline authors in preparation and updating of the ERBP guidelines EDUCATION AND TRAINING October 1998 August 2004 Medicine General University of Medicine and Pharmacy (Romania) October 2011 November 2014 PhD (Romania) PhD started in 2011 and finalized in November 2014, on the evidence for treatment of diabetic patients with developed CKD stage 3b/4/5. ADDITIONAL INFORMATION Expertise 1. MEDICAL AND HEALTH SCIENCES > Clinical medicine Urology and nephrology 2. MEDICAL AND HEALTH SCIENCES > Clinical medicine > Urology and nephrology Nephrology 3. MEDICAL AND HEALTH SCIENCES > Clinical medicine General and internal medicine 4. MEDICAL AND HEALTH SCIENCES > Clinical medicine > Other clinical medicine subjects Clinical trials 5. MEDICAL AND HEALTH SCIENCES > Clinical medicine > Other clinical medicine subjects > Medical statistics Epidemiology 6. MEDICAL AND HEALTH SCIENCES > Clinical medicine > Other clinical medicine subjects > Medical statistics Public health 7. MEDICAL AND HEALTH SCIENCES > Health sciences > Health policy and services Public health policies 8. MEDICAL AND HEALTH SCIENCES > Health sciences > Public and environmental health > Public health Chronic diseases Publications 1: Nistor I, Palmer SC, Craig JC, Saglimbene V, Vecchio M, Covic A, Strippoli GF. Convective versus diffusive dialysis therapies for chronic kidney failure: an updated systematic review of randomized controlled trials. Am J Kidney Dis ;63(6): Impact Factor 2: Nistor I, Palmer SC, Craig JC, Saglimbene V, Vecchio M, Covic A, Strippoli GFM. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease. Cochrane Database of Systematic Reviews. CD doi: / cd pub Impact Factor 3: Covic A, Nistor I, Donciu MD, Dumea R, Bolignano D, Goldsmith D. Erythropoiesis-Stimulating Agents (ESA) for Preventing the Progression of Chronic Kidney Disease: A Meta-Analysis of 19 30/9/17 European Union, Page 1 / 5
2 Studies. Am J Nephrol. 2014;40(3): doi: / Impact Factor 4: Nistor I, Bararu I, Apavaloaie MC, Voroneanu L, Donciu MD, Kanbay M, Nagler EV, Covic A. Vasopressin receptor antagonists for the treatment of heart failure: a systematic review and meta-analysis of randomized controlled trials. Int Urol Nephrol Oct Impact Factor 5: Speeckaert M, Van Biesen W, Delanghe J, Slingerland R, Wiecek A, Heaf J, Drechsler C, Lacatus R, Vanholder R, Nistor I; for the European Renal Best Practice Guideline Development Group on Diabetes in Advanced CKD. Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population? Nephrol Dial Transplant Jan Impact Factor 6: Volovăt C, Cãruntu I, Costin C, Stefan A, Popa R, Volovăt S, Siriopol D, Voroneanu L, Nistor I, Segall L, Covic A. Changes in the histological spectrum of glomerular diseases in the past 16 years in the North-Eastern region of Romania. BMC Nephrol Jul 15;14:148. doi: / Impact Factor 7: Parfeni M, Nistor I, Covic A. A systematic review regarding the association of illness perception and survival among end-stage renal disease patients. Nephrol Dial Transplant Oct;28(10): doi: /ndt/gft Impact Factor 8: Goldsmith D, Covic A, Vervloet M, Cozzolino M, Nistor I; Chronic Kidney Disease-Mineral Bone Disease (CKD-MBD) working group and the European Renal Best Practice (ERBP) advisory board; Chronic Kidney Disease-Mineral Bone Disease CKD-MBD working group and the European Renal Best Practice ERBP advisory board. Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement. Nephrol Dial Transplant May;30(5): doi: /ndt/gfv050. Epub 2015 Mar 4; 3.58 Impact Factor 9: Nistor I, Bolignano D, Haller MC, Nagler E, van der Veer SN, Jager K, Covic A, Webster A, Van Biesen W. Why creating standardized core outcome sets for chronic kidney disease will improve clinical practice. Nephrol Dial Transplant Oct 23. pii: gfv365. [Epub ahead of print] PubMed PMID: Impact Factor 1: Segall L, Nistor I, Van Biesen W, Brown EA, Heaf JG, Lindley E, Farrington K, Covic A. Dialysis modality choice in elderly patients with end-stage renal disease: a narrative review of the available evidence. Nephrol Dial Transplant Dec 15. pii: gfv411. [Epub ahead of print] Review. PubMed PMID: Impact Factor 2: Burlacu A, Siriopol D, Voroneanu L, Nistor I, Hogas S, Nicolae A, Nedelciuc I, Tinica G, Covic A. Atherosclerotic Renal Artery Stenosis Prevalence and Correlations in Acute Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Interventions: Data From Nonrandomized Single-Center Study (REN-ACS) A Single Center, Prospective, Observational Study. J Am Heart Assoc Oct 12;4(10):e doi: /JAHA PubMed PMID: Impact Factor 3: Chazot C, Farrington K, Nistor I, Van Biesen W, Joosten H, Teta D, Siriopol D, Covic A. Pro and con arguments in using alternative dialysis regimens in the frail and elderly patients. Int Urol Nephrol Nov;47(11): doi: /s Epub 2015 Sep 16. PubMed PMID: Impact Factor 4: Onofriescu M, Siriopol D, Voroneanu L, Hogas S, Nistor I, Apetrii M, Florea L, Veisa G, Mititiuc I, Kanbay M, Sascau R, Covic A. Overhydration, Cardiac Function and Survival in Hemodialysis Patients. PLoS One Aug 14;10(8):e doi: /journal.pone ecollection PubMed PMID: ; PubMed Central PMCID: PMC Impact Factor 30/9/17 European Union, Page 2 / 5
3 5: Guideline development group. Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (egfr <45 ml/min). Nephrol Dial Transplant May;30 Suppl 2:ii doi: /ndt/gfv100. PubMed PMID: Impact Factor 6: Coentrão L, Van Biesen W, Nistor I, Tordoir J, Gallieni M, Marti Monros A, Bolignano D. Preferred haemodialysis vascular access for diabetic chronic kidney disease patients: a systematic literature review. J Vasc Access Jul-Aug;16(4): doi: /jva Epub 2015 Feb 3. PubMed PMID: Impact Factor 7: Voroneanu L, Siriopol D, Nistor I, Apetrii M, Hogas S, Onofriescu M, Covic A. Superior predictive value for NTproBNP compared with high sensitivity ctnt in dialysis patients: a pilot prospective observational study. Kidney Blood Press Res. 2014;39(6): doi: / PubMed PMID: Impact Factor 8: Nagler EV, Vanmassenhove J, van der Veer SN, Nistor I, Van Biesen W, Webster AC, Vanholder R. Diagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statements. BMC Med Dec 11;12:1. doi: /s Review. PubMed PMID: ; PubMed Central PMCID: PMC Impact Factor 9: Ballinger AE, Palmer SC, Nistor I, Craig JC, Strippoli GF. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Database Syst Rev. 2014;12:CD doi: / CD pub2. Epub 2014 Dec 9. Review. PubMed PMID: Impact Factor 10: Van Huffel L, Tomson CR, Ruige J, Nistor I, Van Biesen W, Bolignano D. Dietary restriction and exercise for diabetic patients with chronic kidney disease: a systematic review. PLoS One Nov 25;9(11):e doi: /journal.pone ecollection Review. PubMed PMID: ; PubMed Central PMCID: PMC Impact Factor 11: Siriopol D, Canaud B, Stuard S, Mircescu G, Nistor I, Covic A. New insights into the effect of haemodiafiltration on mortality: the Romanian experience. Nephrol Dial Transplant Feb;30(2): doi: /ndt/gfu347. Epub 2014 Nov 13. PubMed PMID: Impact Factor 12: Couchoud C, Bolignano D, Nistor I, Jager KJ, Heaf J, Heimburger O, Van Biesen W; European Renal Best Practice (ERBP) Diabetes Guideline Development Group. Dialysis modality choice in diabetic patients with end-stage kidney disease: a systematic review of the available evidence. Nephrol Dial Transplant Feb;30(2): doi: /ndt/gfu293. Epub 2014 Sep 23. Review. PubMed PMID: Impact Factor 13: Segall L, Nistor I, Covic A. Heart failure in patients with chronic kidney disease: a systematic integrative review. Biomed Res Int. 2014;2014: doi: /2014/ Epub 2014 May 15. Review. PubMed PMID: ; PubMed Central PMCID: PMC Impact Factor 14: Kanbay M, Siriopol D, Nistor I, Elcioglu OC, Telci O, Takir M, Johnson RJ, Covic A. Effects of allopurinol on endothelial dysfunction: a meta-analysis. Am J Nephrol. 2014;39(4): doi: / Epub 2014 Apr 17. PubMed PMID: Impact Factor 15: Onofriescu M, Hogas S, Voroneanu L, Apetrii M, Nistor I, Kanbay M, Covic AC. Bioimpedance-guided fluid management in maintenance hemodialysis: a pilot randomized controlled trial. Am J Kidney Dis Jul;64(1): doi: /j.ajkd Epub 2014 Feb 28. PubMed PMID: Impact Factor 16: Segall L, Moscalu M, Hogaş S, Mititiuc I, Nistor I, Veisa G, Covic A. Protein-energy wasting, as well as overweight and obesity, is a long-term risk factor for mortality in chronic hemodialysis patients. 30/9/17 European Union, Page 3 / 5
4 Int Urol Nephrol Mar;46(3): doi: /s Epub 2014 Jan 29. PubMed PMID: Impact Factor 17: Arnouts P, Bolignano D, Nistor I, Bilo H, Gnudi L, Heaf J, van Biesen W. Glucose-lowering drugs in patients with chronic kidney disease: a narrative review on pharmacokinetic properties. Nephrol Dial Transplant Jul;29(7): doi: /ndt/gft462. Epub 2013 Dec 8. Review. PubMed PMID: Impact Factor 18: Nagler EV, Webster AC, Bolignano D, Haller MC, Nistor I, van der Veer SN, Fouque D, Van Biesen W. European Renal Best Practice (ERBP) Guideline development methodology: towards the best possible guidelines. Nephrol Dial Transplant Apr;29(4): doi: /ndt/gft407. Epub 2013 Sep 29. Review. PubMed PMID: Impact Factor 19: Palmer SC, Nistor I, Craig JC, Pellegrini F, Messa P, Tonelli M, Covic A, Strippoli GF. Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials. PLoS Med. 2013;10(4):e doi: /journal.pmed Epub 2013 Apr 30. Review. PubMed PMID: ; PubMed Central PMCID: PMC Impact Factor 20: Onofriescu M, Mardare NG, Segall L, Voroneanu L, Cuşai C, Hogaş S, Ardeleanu S, Nistor I, Prisadă OV, Sascău R, Covic A. Randomized trial of bioelectrical impedance analysis versus clinical criteria for guiding ultrafiltration in hemodialysis patients: effects on blood pressure, hydration status, and arterial stiffness. Int Urol Nephrol Apr;44(2): doi: /s y. Epub 2011 Jun 19. PubMed PMID: Impact Factor 21: Voroneanu L, Cusai C, Hogas S, Ardeleanu S, Onofriescu M, Nistor I, Prisada O, Sascau R, Goldsmith D, Covic A. The relationship between chronic volume overload and elevated blood pressure in hemodialysis patients: use of bioimpedance provides a different perspective from echocardiography and biomarker methodologies. Int Urol Nephrol Sep;42(3): doi: /s y. Epub 2010 Jun 4. PubMed PMID: Impact Factor 22: Segall L, Mardare NG, Ungureanu S, Busuioc M, Nistor I, Enache R, Marian S, Covic A. Nutritional status evaluation and survival in haemodialysis patients in one centre from Romania. Nephrol Dial Transplant Aug;24(8): doi: /ndt/gfp110. Epub 2009 Mar 17. PubMed PMID: Impact Factor Projects Memberships , Scientific Secretary of ERA-EDTA CME COURSE Renal Failure Academy, 2011 present, Board Member European Renal Best Practice ERBP guidelines 2013-present, Board Member Romanian Society of Nephrology Starting from October 2014: Associate Editor for Clinical Kidney Journal, the second official journal of European Society of Nephrology (ERA-EDTA). Reviewer for: International Urology and Nephrology (nephrology) Nephrology Dialysis Transplantation Cochrane Database of Systematic Reviews Archives of Medical Science American Journal of Kidney Disease 30/9/17 European Union, Page 4 / 5
5 Hemodialysis International Other Relevant Information 30/9/17 European Union, Page 5 / 5
EPO e Ferro in Emodialisi: Il PBM al suo esordio. Lucia Del Vecchio. Divisione di Nefrologia e Dialisi Ospedale A. Manzoni, ASST Lecco
PATIENT BLOOD MANAGEMENT DALLA TEORIA ALLA PRATICA 16 FEBBRAIO 2018 EPO e Ferro in Emodialisi: Il PBM al suo esordio Lucia Del Vecchio Divisione di Nefrologia e Dialisi Ospedale A. Manzoni, ASST Lecco
More informationPrevalence of depression among patients with end stage renal disease
Orginal Article Prevalence of depression among patients with end stage renal disease 1 2 3 Trupti Bodhare, Vidhya Wilson, Sandeep D 1 2 Professor, Department of Community Medicine, Associate Professor,
More informationEast London Community Kidney Service
East London Community Kidney Service Sally Hull, Neil Ashman, Sec Hoong, Nicola Thomas, Helen Rainey April 2017 Haemodialysis/million population What is the Problem? Fast rising ESRD rates in East London
More informationDialysis modality choice in diabetic patients with end-stage kidney disease: a systematic review of the available evidence
Nephrol Dial Transplant (2015) 30: 310 320 doi: 10.1093/ndt/gfu293 Advance Access publication 23 September 2014 Dialysis modality choice in diabetic with end-stage kidney disease: a systematic review of
More informationClinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (egfr <45 ml/min)
Nephrol Dial Transplant (2015) 30: ii1 ii142 doi: 10.1093/ndt/gfv100 Clinical Practice Guideline Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b
More informationComment on European Renal Best Practice Position Statement on Anaemia Management in Chronic Kidney Disease.
Comment on European Renal Best Practice Position Statement on Anaemia Management in Chronic Kidney Disease. Goldsmith D, Blackman A, Gabbay F, June 2013 Kidney Disease: Improving Global Outcomes (KDIGO)
More informationDATE: 25 August 2015 CONTEXT AND POLICY ISSUES
TITLE: Bioimpedance Devices for the Assessment of Body Fluid Volume for Patients Undergoing Dialysis: A Review of the Clinical Effectiveness, Cost-Effectiveness and Guidelines An Update DATE: 25 August
More information( ) , (Donabedian, 1980) We would not choose any treatment with poor outcomes
..., 2013 Amgen. 1 ? ( ), (Donabedian, 1980) We would not choose any treatment with poor outcomes 1. :, 2. ( ): 3. :.,,, 4. :, [Biomarkers Definitions Working Group, 2001]., (William M. Bennet, Nefrol
More informationFIRST RENAL REPLACEMENT
FIRST RENAL REPLACEMENT THERAPY SELECTION IN DIABETIC PATIENTS Dr Cécile Couchoud (REIN registry, France) Davide Bolignano (ERBP, Italy) European Renal Best Practice Prof. Wim Van Biesen Chairman of ERBP
More informationCentre for Kidney Research publications 2015
Centre for Kidney Research publications 2015 1. Alexander SI, Madsen JC. Organ Transplant Tolerance for Children; in Sight for Some. The Journal of Pediatrics. 2015 Nov 12. PubMed PMID: 26581495. Epub
More informationCardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center
Cardiovascular Disease in CKD Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Objectives Describe prevalence for cardiovascular disease in CKD
More informationSoo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital
Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital Agenda Association between Cardiovascular Disease and Type 2 Diabetes Importance of HbA1c Management esp. High risk patients
More informationAssociation Between the Vascular Calcification and High Turnover Radiographic Bone Changes in Chronic Kidney Disease Patients
SP_021 Association Between the Vascular Calcification and High Turnover Radiographic Bone Changes in Chronic Kidney Disease Patients Virayavanich W, MD Department of Diagnostic and Therapeutic Radiology,
More information02/27/2018. Objectives. To Replace or Not to Replace: Nutritional Vitamin D in Dialysis.
To Replace or Not to Replace: Nutritional Vitamin D in Dialysis. Michael Shoemaker-Moyle, M.D. Assistant Professor of Clinical Medicine Objectives Review Vitamin D Physiology Review Current Replacement
More informationDept of Internal Medicine, Central Hospital, Kristianstad (Sweden) Dept of Internal Medicine, Central Hospital, Kristianstad (Sweden)
Curriculum vitae PERSONAL INFORMATION Charles Cline WORK EXPERIENCE June 1984 January 1985 Dept of Internal Medicine, Central Hospital, Kristianstad (Sweden) February 1985 January 1987 Internship Central
More informationThe PROMs Programme in the NHS in England
The PROMs Programme in the NHS in England Veena Raleigh Senior Fellow, The King s Fund HCQI, 7 November 2013 The background Improving NHS quality a government priority since 2008 Quality defined as: effectiveness,
More informationAngiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) To STOP OR Not in Advanced Renal Disease
Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) To STOP OR Not in Advanced Renal Disease Investigator Meeting 12 th September 2017 - Sheffield Prof Sunil Bhandari Consultant
More informationEvidence-based practice in nephrology : Meta-analysis
Evidence-based practice in nephrology : Meta-analysis Paweena Susantitaphong, MD,Ph.D 1-3 1 Associate Professor, Division of Nephrology, Department of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn
More information2017 KDIGO Guidelines Update
2017 KDIGO Guidelines Update Clinic for Hemodialysis Clinical Center University of Sarajevo 13 th Congress of the Balkan cities Association of Nephrology, Dialysis, and Artificial Organs Transplantation
More informationCurriculum Vitae. Saeed Alipour Parsa, M.D., Associate Professor of Cardiology
Curriculum Vitae Saeed Alipour Parsa, M.D., Associate Professor of Cardiology Department of Interventional Cardiology Shahid Modarres hospital Shahid Beheshti University of Medical Sciences PERSONAL DATA
More informationClinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (egfr <45 ml/min)
Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (egfr
More informationDietary Restriction and Exercise for Diabetic Patients with Chronic Kidney Disease: A Systematic Review
RESEARCH ARTICLE Dietary Restriction and Exercise for Diabetic Patients with Chronic Kidney Disease: A Systematic Review Liesbeth Van Huffel 1,2, Charles R. V. Tomson 3, Johannes Ruige 1, Ionut Nistor
More informationElections to EACVI Board
Elections to EACVI Board 2018-2020 Application for the position: EACVI Secretary 1. Your Identity Title Family Name(s) First Name(s) Birth Date Institute/Organisation Department City Country Prof. Di Salvo
More informationDr. Liliana Garneata Assistant Professor of Nephrology Dr Carol Davila Teaching Hospital of Nephrology, Bucharest, Romania
Dr. Liliana Garneata Assistant Professor of Nephrology Dr Carol Davila Teaching Hospital of Nephrology, Bucharest, Romania Nutritional management of CKD: Key-role of ketoanalogues with low protein diets
More information: Ajou University College of Medicine, Suwon, Korea; Ajou University College of Medicine, Graduate
CURRICULUM VITAE NAME Hyun Woo Lee, M.D. EDUCATION 1991.3.-2001.2 : Ajou University College of Medicine, Suwon, Korea; Doctor of Medicine 2004.3-2006.2 Ajou University College of Medicine, Graduate School,
More informationMonth/Year of Review: September 2012 Date of Last Review: September 2010
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationPublication List Version: November 2012
Publication List Version: November 2012 AGE Reader Key Publications Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of
More informationPriority topics for European multidisciplinary guidelines on the management of chronic kidney disease in older adults
Priority topics for European multidisciplinary guidelines on the management of chronic kidney disease in older adults Sabine N. van der Veer a, Wim van Biesen a,b, Pascale Bernaert c, Davide Bolignano
More informationTitle: Statins for haemodialysis patients with diabetes? Long-term follow-up endorses the original conclusions of the 4D study.
Manuscript type: Invited Commentary: Title: Statins for haemodialysis patients with diabetes? Long-term follow-up endorses the original conclusions of the 4D study. Authors: David C Wheeler 1 and Bertram
More informationContrast Induced Nephropathy
Contrast Induced Nephropathy O CIAKI refers to an abrupt deterioration in renal function associated with the administration of iodinated contrast media O CIAKI is characterized by an acute (within 48 hours)
More informationCardiovascular Risk Reduction in Kidney Transplant Recipients
Cardiovascular Risk Reduction in Kidney Transplant Recipients Rainer Oberbauer R.O. AUG 2010 CV Mortality in ESRD compared to the general population R.O.2/32 Modified from Foley et al. AJKD 32 (suppl3):
More informationFlu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance
Flu Watch MMWR Week 3: January 14 to January 2, 218 All data are provisional and subject to change as more reports are received. Geographic Spread South Carolina reported widespread activity this week.
More informationAtrial Fibrillation. 2 nd Annual National Hospitalist Conference San Antonio, TX September 7, 2018
2 nd Annual National Hospitalist Conference San Antonio, TX September 7, 2018, MSc, FACP, SFHM Division of Hospital Medicine Henry Ford Hospital Detroit, USA Clinical Associate Professor of Medicine Wayne
More informationThe 14th Budapest Nephrology School
The 14th Budapest Nephrology School (Nephrology, Hypertension, Dialysis, Transplantation) Under the auspices of ISN and ERA-EDTA 25 30 August, 2007 Semmelweis University International Nephrology Research
More informationFlu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance
Flu Watch MMWR Week 4: January 21 to January 27, 218 All data are provisional and subject to change as more reports are received. Geographic Spread South Carolina reported widespread activity this week.
More informationSensipar. Sensipar (cinacalcet) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.46 Subject: Sensipar Page: 1 of 5 Last Review Date: June 22, 2018 Sensipar Description Sensipar (cinacalcet)
More informationSarcopenia. Juan Jesús Carrero. Dept Medical Epidemiology and Biosta9s9cs Karolinska Ins9tutet, Sweden.
Sarcopenia Juan Jesús Carrero Dept Medical Epidemiology and Biosta9s9cs Karolinska Ins9tutet, Sweden. 1 Revisi&ng the concept of sarcopenia in geriatric diseases Nephrol Dial Transplant. 2017 Jul 1;32(7):1127-1136.
More informationCurriculum Vitae. Qualifications. Training
Curriculum Vitae Name: Hamid Tayebi Khosroshahi Gender: Male Marital status: Married Date of birth: 5/6/1964 Place of Birth: Tabriz-Iran Nationality: Iranian Work address: Nephrology section, Department
More informationState Profile for FY 2018 for Dialysis Patients and Facilities - STATE SAMPLE
Dear State Surveyor: State Profile for FY 2018 for Dialysis Patients and Facilities - STATE SAMPLE This report is designed to provide a comparative summary of treatment patterns and patient outcomes for
More informationDietary treatment of adult patients with Cystic Fibrosis Related Diabetes
Dietary treatment of adult patients with Cystic Fibrosis Related Diabetes Francis Hollander, RD Dietician University Medical Center Julius Center for Health Sciences and Primary Care Department of Dietetics
More informationDialysis Initiation and Optimal Vascular Access: Outcomes and Mortality
Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Shannon H. Norris, BSN, RN June 6, 2018 Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality DISCUSSION: End Stage
More informationDyslipidemias in chronic kidney disease: Current guidelines and future perspectives
Epidemiology Page 1 of 5 Dyslipidemias in chronic kidney disease: Current guidelines and future perspectives B Afsar* Abstract Introduction Dyslipidemia is a major problem in chronic kidney disease (CKD)
More informationegfr 34 ml/min egfr 130 ml/min Am J Kidney Dis 2002;39(suppl 1):S17-S31
Update on Renal Therapeutics Caroline Ashley Lead Pharmacist Renal Services UCL Centre for Nephrology, Royal Free Hospital, London Kongress für Arzneimittelinformation January 2011 What are we going to
More informationClinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (egfr <45 ml/min/1.
Nephrol Dial Transplant (2016) 31: ii1 ii66 doi: 10.1093/ndt/gfw356 on management of older patients with chronic kidney disease stage 3b or higher (egfr
More informationImplementation of an Interprofessional Team to Prevent Inpatient Hypoglycemic Events. September 13, 2016
Implementation of an Interprofessional Team to Prevent Inpatient Hypoglycemic Events September 13, 2016 St Joseph s Health Fast Facts Founded 1869 by Sisters of St. Francis Patient Volumes (2014) Inpatient
More informationAttivazione selettiva dei VDR nella CKD-MBD: dalla conservativa alla dialisi
Attivazione selettiva dei VDR nella CKD-MBD: dalla conservativa alla dialisi Mario Cozzolino, MD, PhD, FERA Dipartimento di Scienze della Salute Università di Milano UO Nefrologia e Dialisi Laboratorio
More informationMichelle Irving. Poche Centre for Indigenous Health, Population Oral Health, Faculty of Dentistry, Westmead, NSW, 2145 E:
Michelle Irving Poche Centre for Indigenous Health, Population Oral Health, Faculty of Dentistry, Westmead, NSW, 2145 E: michelle.irving@sydney.edu Current positions Research Fellow 2013-current Poche
More informationSecondary Hyperparathyroidism: Where are we now?
Secondary Hyperparathyroidism: Where are we now? Dylan M. Barth, Pharm.D. PGY-1 Pharmacy Resident Mayo Clinic 2017 MFMER slide-1 Objectives Identify risk factors for the development of complications caused
More informationIMPLEMENTATION OF THE CKD-MBD PRACTICE. Goce Spasovski, R. Macedonia
IMPLEMENTATION OF THE CKD-MBD GUIDELINES Introduction INTO CLINICAL to Renagel PRACTICE Goce Spasovski, R. Macedonia Antalya, Turkey, September 16 2012 Session Objectives Guidelines needs and controversy
More informationMonth/Year of Review: May 2014 Date of Last Review: September New Drug Evaluation: Sucrofferic Oxyhydroxide (Velphoro )
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationNon Conventional cardiovascular risk factors in CKD
Non Conventional cardiovascular risk factors in CKD Death rates for major cardiovascular diseases have decreased in the United States Cooper, R, Cutler, J, Desvigne-Nickens, P, et al. Circulation 2000;
More informationPublications from the UKROC Programme
Publications from the UKROC Programme Published peer reviewed papers Turner-Stokes L, Turner-Stokes T. The use of standardised outcome measures in rehabilitation centres in the UK Clinical Rehabilitation
More informationAppendix 1 (as supplied by the authors): Databases and definitions used.
Appendix 1 (as supplied by the authors): Databases and definitions used. Table e1: The Institute for Clinical Evaluative Sciences databases used in this study and their descriptions Database Ontario Health
More informationProtocol. Kidney Transplant
Protocol Kidney Transplant (70301) Medical Benefit Effective Date: 01/01/15 Next Review Date: 03/18 Preauthorization Yes Review Dates: 05/09, 05/10, 05/11, 05/12, 05/13, 05/14, 11/14, 11/15, 11/16, 03/17
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/29973 holds various files of this Leiden University dissertation. Author: Meuwese, Christiaan Lucas Title: Nontraditional cardiovascular risk factors in
More informationHemodiafiltration in Europe : Trends, Practices, Outcomes & Perspectives
Hemodiafiltration in Europe : Trends, Practices, Outcomes & Perspectives Prof. Bernard Canaud Nephrology, Dialysis and Intensive Care Lapeyronie Hospital CHRU Montpellier - France Opening remarks and special
More informationOnline Haemodiafiltration
The 20th Budapest Nephrology School August, 30,2013 Online Haemodiafiltration is it really the Technique of the Future? Prof. Francesco Locatelli MD FRCP Department of Nephrology, Dialysis and Renal Transplant
More informationNuove terapie in ambito Nefrologico: Etelcalcetide (AMG-416)
Nuove terapie in ambito Nefrologico: Etelcalcetide (AMG-416) Antonio Bellasi, MD, PhD U.O.C. Nefrologia & Dialisi ASST-Lariana, Ospedale S. Anna, Como, Italy Improvement of mineral and bone metabolism
More informationTHE IMPACT OF SERUM PHOSPHATE LEVELS IN CKD-MBD PROGRESSION
THE IMPACT OF SERUM PHOSPHATE LEVELS IN CKD-MBD PROGRESSION Mario Cozzolino, MD, PhD, Fellow of the European Renal Association Department of Health Sciences University of Milan Renal Division & Laboratory
More informationThis document was created on 07 January 2005 and has been printed from
1 Spontaneous Adverse Event Reporting Information Introduction This document provides information regarding spontaneous adverse event reports received concerning patients taking rosuvastatin, which relates
More informationNATIONAL BANK OF POLAND
NATIONAL BANK OF POLAND RECENT TRENDS IN THE REAL ESTATE MARKET INTERNATIONAL CONFERENCE THE HOUSING PRICES IN ROMANIA - recent developments - Ph.D. Andrei RĂDULESCU Senior Economist Researcher, IWE, Romanian
More informationVitamin D: Conflict of Interest Statement Corporate. Outline 7/5/2016
Vitamin D: What s New and Not? Clifford J Rosen MD Maine Medical Center Research Institute rosenc@mmc.org Conflict of Interest Statement Corporate NO STOCKS or EQUITY Editor UpToDate, New England Journal
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Cardiovascular Risk Factors
Cardiovascular Risk Factors ROB WALKER (Dunedin, New Zealand) Lipid-lowering therapy in patients with chronic kidney disease Date written: January 2005 Final submission: August 2005 Author: Rob Walker
More informationSetting the standard
SCLEROSTIN in NEPHROLOGY MOST REFERENCED OPTIMIZED FOR CLINICAL SAMPLES Setting the standard for clinical research. SCLEROSTIN A BONE-RELATED PROTEIN URINE PROTOCOL AVAILABLE Sclerostin ELISA - Assay Characteristics
More informationStadien der Progression bei CKD
Stadien der Progression bei CKD Complications Normal Increased risk Damage GFR Kidney failure CKD death Screening for CKD risk factors CKD risk reduction; Screening for CKD Diagnosis & treatment; Treat
More informationRenal Association Clinical Practice Guideline in Mineral and Bone Disorders in CKD
Nephron Clin Pract 2011;118(suppl 1):c145 c152 DOI: 10.1159/000328066 Received: May 24, 2010 Accepted: December 6, 2010 Published online: May 6, 2011 Renal Association Clinical Practice Guideline in Mineral
More informationUniversity of Pittsburgh Critical Care Medicine
University of Pittsburgh Critical Care Medicine www.ccm.pitt.edu Intensivist-led Donor Care in the Intensive Care Unit Raghavan Murugan MD, MS, FRCP Assistant Professor Dept. of Critical Care Medicine
More informationObjectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives
The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA
More informationMEDICAL POLICY SUBJECT: NUTRITIONAL THERAPY
MEDICAL POLICY PAGE: 1 OF: 6 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.
More informationIncidence of native renal biopsy in Scotland
G2 Incidence of native renal biopsy in Scotland Introduction For many patients with renal disorders, accurate interpretation of a percutaneous renal biopsy is important to establish the diagnosis and to
More informationProgress Report of the activities of the Working Group «Hypertension and the Kidney»
Progress Report of the activities of the Working Group «Hypertension and the Kidney» 2017-2018 Contents Members... 2 WG meetings... 2 Fibromuscular Dysplasia (FMD)... 5 Hypertension in dialysis... 6 Hypertension
More informationResults: 1 to 200 of 204
PubMed (Takagi H[First Author] OR Kato T[First Author] OR Sekino S[First A Display Settings: Summary, 200 per page, Sorted by Recently Added Results: 1 to 200 of 204 Filters activated: Publication date
More informationImproved Assessment of Aortic Calcification in Japanese Patients Undergoing Maintenance Hemodialysis
ORIGINAL ARTICLE Improved Assessment of Aortic Calcification in Japanese Patients Undergoing Maintenance Hemodialysis Masaki Ohya 1, Haruhisa Otani 2,KeigoKimura 3, Yasushi Saika 4, Ryoichi Fujii 4, Susumu
More informationEuropean best practice quo vadis? From European best practice guidelines (EBPG) to European renal best practice (ERBP)
Nephrol Dial Transplant (2008) 23: 2162 2166 doi: 10.1093/ndt/gfn238 Advance Access publication 9 May 2008 Editorial Review European best practice quo vadis? From European best practice guidelines (EBPG)
More informationTable of Included Studies for Early versus Late Referral Systematic Review
University of New England From the SelectedWorks of Neil Smart 2011 Table of Included Studies for Early versus Late Referral Systematic Review Neil A Smart, Assoc. Prof. Available at: https://works.bepress.com/neil_smart/8/
More informationCase # 2 3/27/2017. Disclosure of Relevant Financial Relationships. Clinical history. Clinical history. Laboratory findings
Case # 2 Christopher Larsen, MD Arkana Laboratories Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to influence or control the content
More informationTherapeutic golas in the treatment of CKD-MBD
Therapeutic golas in the treatment of CKD-MBD Hemodialysis clinic Clinical University Center Sarajevo Bantao, 04-08.10.2017, Sarajevo Abbvie Satellite symposium 06.10.2017 Chronic Kidney Disease Mineral
More informationPaul R. Bowlin, M.D. University of Colorado Denver. May 12 th, 2008
Paul R. Bowlin, M.D. University of Colorado Denver May 12 th, 2008 Presentation Overview Background / Definitions History Indications for initiation of therapy Outcomes Studies Conclusions Questions Background
More informationCATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care
CATHETER REDUCTION Angelo N. Makris, M.D. Medical Director Chicago Access Care Objectives Discuss tools/techniques proven to improve AVF rates & decrease catheter rates Implement a change process in your
More informationClinical praxis for assessment of dry weight in Sweden and Denmark: A mixed-methods study
Hemodialysis International 2016; 20:111 119 Hemodialysis International 2015; : Volume Control Clinical praxis for assessment of dry weight in Sweden and Denmark: A mixed-methods study Jenny STENBERG, 1
More informationChronic renal failure
Chronic renal failure Alexander Woywodt MD FRCP Consultant Physician and Nephrologist / Hon. Senior Lecturer Lancashire Teaching Hospitals NHS Foundation Trust Carnforth 13 th th October 2010 Menu Epidemiology
More informationAccepted Manuscript. The Golden Ratio. Tomasz A. Timek, MD PhD
Accepted Manuscript The Golden Ratio Tomasz A. Timek, MD PhD PII: S0022-5223(19)30016-9 DOI: https://doi.org/10.1016/j.jtcvs.2018.12.089 Reference: YMTC 13991 To appear in: The Journal of Thoracic and
More informationA Retrospective Comparison of the Safety and Efficacy of 3 months vs. 6 months
1 A Retrospective Comparison of the Safety and Efficacy of 3 months vs. 6 months Valganciclovir for Cytomegalovirus Prophylaxis in Renal Transplant Recipients Investigators: Ashley Masys, BScPharm, ACPR(c)
More informationMetabolic Bone Disease Related to Chronic Kidney Disease
Metabolic Bone Disease Related to Chronic Kidney Disease Deborah Sellmeyer, MD Director, Johns Hopkins Metabolic Bone Center Dept of Medicine, Division of Endocrinology Disclosure DSMB member for denosumab
More informationMEDICAL POLICY SUBJECT: CARDIAC REHABILITATION
MEDICAL POLICY PAGE: 1 OF: 6 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.
More informationCurrent situation and future of renal anemia treatment. FRANCESCO LOCATELLI
Antalya May 20, 2010 12 National Congress of Turkish Society of Hypertension and Renal Disease Current situation and future of renal anemia treatment. FRANCESCO LOCATELLI Department of Nephrology, Dialysis
More informationQuarterly Dialysis Facility Compare - Preview for April 2018 Report DFC Dialysis Facility State: XX Network: 99 CCN: SAMPLE
Quarterly Dialysis Facility Compare -- Preview for April 2018 Report This Quarterly DFC Preview Report includes data specific to CCN(s): 999999 Purpose of the Report This report provides you with advance
More informationAnticholinergic medication use for female overactive bladder in the ambulatory setting in the United States.
Página 1 de 6 PubMed darifenacin vs solifenacin Display Settings:, Sorted by Recently Added Results: 5 1. Int Urogynecol J. 2013 Oct 25. [Epub ahead of print] Anticholinergic medication use for female
More informationDate : September Permit/License or Registration Application. Permit/License/ Notification/ Registration Description. Remark
Number 1. s 29 Jul 13 N/A Environmental Permit to construct the Passenger Clearance and associated works of the Hong Kong Zhuhai and Macao Bridge Boundary Crossing Facilities EP-353/2009/G 06 Aug 13 N/A
More informationOverview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station
Click here for the corrections made < Reference > December 3, 212 Tokyo Electric Power Company Overview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station * As of
More informationCURRICULUM VITAE ANWAR SHAFI, MD
CURRICULUM VITAE ANWAR SHAFI, MD Work Address Postal address Southern Illinois University School of Medicine P.O. Box l9658 Springfield, IL 62794-9658 E-Mail Address Present Position ashafi@siumed.edu
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Mode of dialysis at initiation GUIDELINES
Date written: September 2004 Final submission: February 2005 Mode of dialysis at initiation GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationHypertension Management Controversies in the Elderly Patient
Hypertension Management Controversies in the Elderly Patient Juan Bowen, MD Geriatric Update for the Primary Care Provider November 17, 2016 2016 MFMER slide-1 Disclosure No financial relationships No
More informationPublication Plan 2017
Publication Plan 2017 A passion for turning high quality, independent research insights into actionable commercial intelligence. Why Spherix Global Insights? Our independent reports are designed, developed,
More informationINSPIRED BY LIFE B. BRAUN DIALYZERS
INSPIRED BY LIFE B. BRAUN DIALYZERS OUR COMMITMENT. FOR LIFE. The Diacap Pro and xevonta dialyzers offer a broad range of high-quality dialyzers for individual treatment needs. It began in 1839, inspired
More informationMEDICAL POLICY SUBJECT: CARDIAC REHABILITATION. POLICY NUMBER: CATEGORY: Therapy/ Rehabilitation
MEDICAL POLICY SUBJECT: CARDIAC REHABILITATION, 08/25/17 PAGE: 1 OF: 6 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product,
More informationMiklos Z. Molnar, MD, PhD, FASN - Curriculum Vitae. Personal Statistics: Born: February 17th, 1977 Place of Birth: Budapest, Hungary.
Miklos Z. Molnar, MD, PhD, FASN - Curriculum Vitae Personal Statistics: Born: February 17th, 1977 Place of Birth: E-mail: mzmolnar@uthsc.edu Education: 1991-1995 High School, Budapest June 7, 1995 09/1995-08/2001
More informationCinacalcet treatment in advanced CKD - is it justified?
Cinacalcet treatment in advanced CKD - is it justified? Goce Spasovski ERBP Advisory Board member University of Skopje, R. Macedonia TSN Congress October 21, 2017, Antalya Session Objectives From ROD to
More informationTRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA
& TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA 2002-2008 Halima Resić* 1, Enisa Mešić 2 1 Clinic for Hemodialysis, University of Sarajevo Clinics Centre, Bolnička 25, 71000 Sarajevo, Bosnia
More informationBOMBAY HOSPITAL TRUST
BOMBAY HOSPITAL TRUST Consultant Speciality Qualifications Fellowships Area Of Interest Experience : Dr Hardik Shah : Nephrology : MD (Medicine), DNB (Nephrology) : International Society Of Nephrology
More information